![](/wp-content/uploads/2022/01/Other-Research-Resources-440x300-1.png")
Posts
;
The NCTN, albeit imperfect, serves a critical role in advancing cancer care by:
1)Conducting pragmatic trials pharma/industry would never sponsor
2)Enrolling across a diverse network (>3K sites) representative of a “real world” population
Great editorial @TedHong9 @TGeorgeMD👏
For decades, NIH has been the nation’s cornerstone of medical research, driving discoveries that have led to groundbreaking treatments, increased survival rates, and enhanced quality of life for patients. @AACR will continue to urge Congress to support this critical institution.
#ComboMATCH Treatment Trial E5, led by @kspencer725 of @Perlmutter_CC and @DocDustyD of @UWCarbone, is a randomized phase 2 study of #sotorasib with or without #panitumumab in advanced #SolidTumors. Learn more here: https://bit.ly/combomatch-e5 #PrecisionMedicine
About Us
The ECOG-ACRIN Cancer Research Group is a strong network of nearly 1400 academic and community-based cancer centers and hospitals in the United States and around the world. We design and conduct biomarker-driven research involving adults who have or are at risk of developing cancer. Learn More
Scientific Pursuits
We are dedicated to improving life for adults affected by cancer. Through our member sites, we are pursuing a robust clinical and translational research portfolio that focuses on precision oncology, immunotherapy, reducing over-treatment and over-diagnosis, leveraging novel biomarker platforms to inform therapeutic decision-making, and advancing standards of care in broad populations of cancer patients and those at risk. Learn More
ECOG-ACRIN by the Numbers
37
Active Clinical Trials
1400
Participating Institutions
67
International Sites
21000
Individual Members
Scientifically rigorous, broadly multidisciplinary, organizationally robust, and internationally respected, the Group is a vibrant component of the National Cancer Institute (NCI) National Clinical Trials Network (NCTN). In addition, we are a Research Base in the NCI Community Oncology Research Program (NCORP).
